Epstein Secrets

onal-security.html> (11/13, 18.61M) op-ed, Susan Rice, a member of the Biden-Harris transition advisory

<https://www.washingtontimes.corn/news/2020/nov/15/biden-adviser-ron-klain-trump-stonewalling-harming/> EFTA00137221 (11/15, 492K), which reports Klain "said Mr. Biden's team will begin consulting with Pfizer and other vaccine makers this week but they would like to be able to speak with key officia

n made after the election as the Biden team continues to wait for access government officials and resources to begin the formal transition process." Klain said, "There's a lot of things that are going to have to wait until Joe Biden is president, but this is not one of them.... This is a national cris

In a New York Times (11/13, 18.61M) op-ed, Susan Rice, a member of the Biden-Harris transition advisor

g it a `giant logistical project;" and he "said the GSA's stonewalling is making that difficult." The AP (11/15, Alonso-Zaldivar, Weissert) reports Klain "said Biden's experts also need a detailed understanding of distribution plans being finalized by the Department of Health and Human Services and t

dlined "Biden Turns Up Pressure for Administration Recognition" provides similar coverage, as does the Washington Times (11/15, 492K), which reports Klain "said Mr. Biden's team will begin consulting with Pfizer and other vaccine makers this week but they would like to be able to speak with key offici

In a New York Times (11/13, 18.61M) op-ed, Susan Rice, a member of the Biden-Harris transition advisor

g it a `giant logistical project;" and he "said the GSA's stonewalling is making that difficult." The AP (11/15, Alonso-Zaldivar, Weissert) reports Klain "said Biden's experts also need a detailed understanding of distribution plans being finalized by the Department of Health and Human Services and t

dlined "Biden Turns Up Pressure for Administration Recognition" provides similar coverage, as does the Washington Times (11/15, 492K), which reports Klain "said Mr. Biden's team will begin consulting with Pfizer and other vaccine makers this week but they would like to be able to speak with key offici

In a New York Times (11/13, 18.61M) op-ed, Susan Rice, a member of the Biden-Harris transition advisor

g it a `giant logistical project;" and he "said the GSA's stonewalling is making that difficult." The AP (11/15, Alonso-Zaldivar, Weissert) reports Klain "said Biden's experts also need a detailed understanding of distribution plans being finalized by the Department of Health and Human Services and t

dlined "Biden Turns Up Pressure for Administration Recognition" provides similar coverage, as does the Washington Times (11/15, 492K), which reports Klain "said Mr. Biden's team will begin consulting with Pfizer and other vaccine makers this week but they would like to be able to speak with key offici

Biden also intends to address moves by Republican- led state legislatures to roll back voting expansions that contributed to Donald Trump's defeat." Rice said, "It's a matter of real concern because we ought to be in the business of encouraging and enabling all Americans who are eligible to vote, to b

er than it's ever been. We're moving it to the states faster, with more certainty and clarity, but there are just some limitations on this process." Klain added, "We need more vaccine, we need more vaccinations, we need more places to give the vaccinations. We are working on all three of those things.